Please assess the completion status of the following clinical trial:

Trial Title: A Phase III Trial to Assess the Safety and Efficacy of Plant Cell Expressed GCD in Patients With Gaucher Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females, 18 years or older~* Confirmed enzymatic diagnosis of Gaucher disease~* Splenomegaly defined as greater than eight times the expected volume (measured volume divided by estimated volume (0.2% of body weight)\] as determined by MRI volumetric analysis~* Female patients of child-bearing potential who agree to use a medically acceptable method of contraception~* Thrombocytopenia (defined as platelet counts below the lower limit of normal) and/or anemia (defined by hemoglobin level at least 1 g/dL below normal range according to sex and age).~* Patients who have not received ERT in the past or patients whoc have not received ERT in the past 12 months and have a negative anti-glucocerebrosidase antibody test.~* Patients who have not received substrate reduction therapy (SRT) in the past 12 months.~* Ability to provide a written informed consent.~Exclusion Criteria:~* Currently taking another experimental drug for any condition~* Pregnant or nursing~* Presence of HIV and/or, HBsAg and/or hepatitis C infections~* Presence of severe neurological signs and symptoms, defined as complete ocular paralysis, overt myoclonus or history of seizures, characteristic of neuronopathic Gaucher disease.~* Previous anaphylactoid reaction to Cerezyme® or Ceredase®.~* History of allergy to carrots.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- prGCD 30 Units/kg (Type: EXPERIMENTAL): None
- prGCD 60 Units/kg (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).